Quxing Wei Selected Research

Body Weight (Weight, Body)

1/2023	The oligosaccharides of Xiasangju alleviates dextran sulfate sodium-induced colitis in mice by inhibiting inflammation.
1/2021	FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quxing Wei Research Topics

Disease

2	Inflammation (Inflammations) 01/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2021
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
1	Colitis 01/2023
1	Diabetic Cardiomyopathies 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hyperglycemia 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021

Drug/Important Bio-Agent (IBA)

1	OligosaccharidesIBA 01/2023
1	Dextran SulfateIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2022
1	FTZ formulaIBA 01/2021
1	zhenshu tiaozhi formulaIBA 01/2021
1	fufang-zhenzhu-tiaozhiIBA 01/2021
1	CollagenIBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Therapeutic UsesIBA 01/2021

Therapy/Procedure

1	Oral Administration 01/2023
1	Therapeutics 01/2022